115 related articles for article (PubMed ID: 36921275)
1. Inclusion of Nitrofurantoin into the Realm of Cancer Chemotherapy via Biology-Oriented Synthesis and Drug Repurposing.
Elzahhar PA; Nematalla HA; Al-Koussa H; Abrahamian C; El-Yazbi AF; Bodgi L; Bou-Gharios J; Azzi J; Al Choboq J; Labib HF; Kheir WA; Abu-Serie MM; Elrewiny MA; El-Yazbi AF; Belal ASF
J Med Chem; 2023 Apr; 66(7):4565-4587. PubMed ID: 36921275
[TBL] [Abstract][Full Text] [Related]
2. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231.
Abbasi Gamasaee N; Radmansouri M; Ghiasvand S; Shahriari F; Zare Marzouni H; Aryan H; Jangholi E; Javidi MA
Arch Iran Med; 2018 Sep; 21(9):387-392. PubMed ID: 30221528
[TBL] [Abstract][Full Text] [Related]
3. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic induction mediated p53 mechanism and Caspase-3 activity by novel promising cyanoacrylamide derivatives in breast carcinoma.
Mohamed MF; Samir N; Ali A; Ahmed N; Ali Y; Aref S; Hossam O; Mohamed MS; Abdelmoniem AM; Abdelhamid IA
Bioorg Chem; 2017 Aug; 73():43-52. PubMed ID: 28601699
[TBL] [Abstract][Full Text] [Related]
5. Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.
Liu N; Tian H; Zhang G; Sun N; Wang S
Med Oncol; 2021 Nov; 39(1):16. PubMed ID: 34837558
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
[TBL] [Abstract][Full Text] [Related]
7. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
8. Recombinant GnRH-p53 protein sensitizes breast cancer cells to 5-fluorouracil-induced apoptosis in vitro and in vivo.
Lu Y; Zhang Z; Yan Z; Chen L; Deng W; Lotze M; Wang Z; Lin X; Li LY
Apoptosis; 2013 Oct; 18(10):1214-23. PubMed ID: 23801079
[TBL] [Abstract][Full Text] [Related]
9. Nitrofurazone repurposing towards design and synthesis of novel apoptotic-dependent anticancer and antimicrobial agents: Biological evaluation, kinetic studies and molecular modeling.
El-Wakil MH; Meheissen MA; Abu-Serie MM
Bioorg Chem; 2021 Aug; 113():104971. PubMed ID: 34051413
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53.
Li Z; Xu X; Li Y; Zou K; Zhang Z; Xu X; Liao Y; Zhao X; Jiang W; Yu W; Guo W; Chen Y; Li Y; Chen M; Deng WG; Li L; Zou L
Cell Physiol Biochem; 2018; 45(5):1772-1786. PubMed ID: 29495002
[TBL] [Abstract][Full Text] [Related]
12. A new pyrrole based small molecule from Tinospora cordifolia induces apoptosis in MDA-MB-231 breast cancer cells via ROS mediated mitochondrial damage and restoration of p53 activity.
Rashmi KC; Harsha Raj M; Paul M; Girish KS; Salimath BP; Aparna HS
Chem Biol Interact; 2019 Feb; 299():120-130. PubMed ID: 30543781
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.
Azmi AS; Philip PA; Aboukameel A; Wang Z; Banerjee S; Zafar SF; Goustin AS; Almhanna K; Yang D; Sarkar FH; Mohammad RM
Curr Cancer Drug Targets; 2010 May; 10(3):319-31. PubMed ID: 20370686
[TBL] [Abstract][Full Text] [Related]
14. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
[TBL] [Abstract][Full Text] [Related]
15. Taurine induces the apoptosis of breast cancer cells by regulating apoptosis-related proteins of mitochondria.
Zhang X; Lu H; Wang Y; Liu C; Zhu W; Zheng S; Wan F
Int J Mol Med; 2015 Jan; 35(1):218-26. PubMed ID: 25395275
[TBL] [Abstract][Full Text] [Related]
16. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer.
An N; Sun Y; Ma L; Shi S; Zheng X; Feng W; Shan Z; Han Y; Zhao L; Wu H
Arch Med Res; 2020 Apr; 51(3):224-232. PubMed ID: 32147288
[TBL] [Abstract][Full Text] [Related]
17. Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.
Marzec KA; Lin MZ; Martin JL; Baxter RC
Oncotarget; 2015 Sep; 6(29):26583-98. PubMed ID: 26378048
[TBL] [Abstract][Full Text] [Related]
18. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone causes Bax- and Bak-mediated apoptosis in human breast cancer cells and inhibits orthotopic xenograft growth in vivo.
Sehrawat A; Arlotti JA; Murakami A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(2):429-41. PubMed ID: 23053663
[TBL] [Abstract][Full Text] [Related]
20. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
